CRISPR/anti-CRISPR genome editing in Clostridium beijerinckii.
- 2026-01
- Journal of biotechnology 409
- PubMed: 41202983
- DOI: 10.1016/j.jbiotec.2025.11.002
Study Design
- Methods
- Inducible expression of classical CRISPR-Cas9 components with anti-CRISPR protein AcrIIA4 to tightly regulate Cas9 activity, applied to Clostridium beijerinckii DSM 6423.
The development of CRISPR technologies has revolutionized genome editing. However, in bacteria, CRISPR-based methods can be difficult to implement due to the cytotoxicity of CRISPR-associated proteins, which often impair or entirely prevent transformation. In this work, we combine inducible expression of classical CRISPR-Cas9 components with the anti-CRISPR protein AcrIIA4 from Listeria monocytogenes to tightly regulate Cas9 activity. Using this approach, we demonstrate efficient and iterative genome editing in the genetically recalcitrant Clostridium beijerinckii DSM 6423. While deletion of upp alone was not sufficient to render the strain sensitive to 5-fluorouracil, the additional deletion of a second gene involved in the uracil salvage pathway conferred resistance to the drug and validated our gene editing strategy. Collectively, our results show that CRISPR/anti-CRISPR systems can overcome a key limitation of CRISPR-based genome editing and may offer a broadly applicable strategy for engineering otherwise intractable bacterial species.
Research Insights
| Supplement | Dose | Health Outcome | Effect Type | Effect Size | Source |
|---|